Cytotoxic and Nitric Oxide Inhibition Activities of Propolis Extract along with Microencapsulation by Complex Coacervation
In this study, cytotoxicity of ethanol extract of propolis (EEP) originating from Sivas, Turkey was screened against several cancer cell lines, namely PC-3, U87MG, A-549, mPANC96, CaCo-2, MCF-7, HeLa, MDA-MB-231 and a non-tumor cell line HEK293 by MTT assay. The inhibition levels of inducible nitric oxide synthase (iNOS) were also determined by using RAW 264.7 macrophage cells following lipopolysaccharide (LPS) treatment. EEP exhibited significant cytotoxic nitric oxide inhibition activities with an IC50 value of 0.1 ± 0.1 μg/ml indicating a high potential as an anti-inflammatory agent. In spite of these promising results and the fact that propolis is a highly nutritive substance, its low solubility and bitter taste limit the applications as a natural supplement. Encapsulation might serve as a good strategy in order to overcome these problems. Complex coacervation was applied where the main focus was on surfactant type, polymer ratio (alginate:gelatin), stirring rate and concentration of core material. The mean particle size of unloaded microparticles were 22.62 μm obtained with gelatin:alginate ratio of 1:1 at a stirring rate of 1400 rpm with 2 ml of 1 % (w/v) sodium carboxymethyl cellulose (Na-CMC), whereas addition of EEP at a concentration of 100 mg/ml increased the mean particle size to 36.44 μm and yielded an encapsulation efficiency of 98.77 %. The cytotoxicities of EEP loaded microparticles were also assessed both on MCF-7 and MDA-MB-231 where similar results were achieved as free EEP which can enhance the possible use of propolis extract in the industry as a natural supplement.
KeywordsMicroencapsulation Complex coacervation Propolis Cytotoxicity Nitric oxide
Access to AREL is highly appreciated.
Compliance with Ethical Standards
Conflict of Interest
The authors declare no conflicts of interest.
- 3.Nori MP, Favaro-Trindade CM, Alencar SM, Thomazini M, Camargo Balieiro JC, Castillo CJC (2011) Microencapsulation of propolis extract by complex coacervation. Food Sci Technol 44:429–435Google Scholar
- 15.Choudhari MK, Haghniaz R, Rajwade JM, Paknikar KM (2013) Anticancer activity of indian stingless bee propolis: an in vitro study. Evid Based Complement Alternat Med 2013:928280. doi: 10.1155/2013/928280
- 18.Xuan H, Li Z, Yan H, Sang Q, Wang K, He Q, Wang Y, Hu F (2014) Antitumor activity of chinese propolis in human breast cancer MCF-7 and MDA-MB-231 cells. Evid Based Complement Alternat Med. 2014:280120. doi: 10.1155/2014/280120
- 21.Olszanecki R, Gêbska A, Kozlovski VI, Gryglewski RJ (2002) Flavonoids and nitric oxide synthase. J Physiol Pharmacol 53(4):571–584Google Scholar
- 26.Rocha-Selmi GA, Favaro-Trindade CS, Ferreira Grossoa CR (2013) Morphology, stability, and application of lycopene microcapsules produced by complex coacervation. J Chem. 2013:982603. doi: 10.1155/2013/982603
- 28.Gordevic´ V, Balancˇ B, Belsˇcˇak-Cvitanovic´ A, Levic´ S, Trifkovic´ S, Kalusˇevic´ A, Kostic´ I, Komes D, Bugarski B, Nedovic V (2014) Trends in encapsulation technologies for delivery of food bioactive compounds. Food Eng Rev:1–39Google Scholar